circRNA: A New Biomarker and Therapeutic Target for Esophageal Cancer

Katsutoshi Shoda1, Yuki Kuwano2, Daisuke Ichikawa1

  • 1First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi 409-3898, Japan.

Biomedicines
|July 27, 2022
PubMed

Insights

Circular RNAs (circRNAs) are stable molecules involved in gene regulation. This review covers circRNA biology and their potential as cancer biomarkers and therapeutic targets, especially for esophageal cancer.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Circular RNAs (circRNAs) are endogenous non-coding RNAs with a unique closed-loop structure.
  • They are generated via back-splicing and play roles in gene regulation, including splicing and miRNA sponging.
  • circRNAs are highly stable and abundant in differentiated cells like the brain.

Purpose of the Study:

  • To review the biogenesis and biological functions of circRNAs.
  • To summarize recent advances in utilizing circRNAs as biomarkers and therapeutic targets in cancer.
  • To focus on the role of circRNAs in esophageal cancer.

Main Methods:

  • Literature review of recent reports on circRNA biogenesis, function, and cancer applications.
  • Cataloging studies on circRNAs in tumorigenesis and metastasis.
  • Focusing on circRNAs in esophageal cancer research.

Main Results:

  • circRNAs are differentially expressed in cancer cells, with their dysfunction linked to tumorigenesis and metastasis.
  • Numerous circRNAs show potential as biomarkers for cancer detection and prognosis.
  • circRNAs are emerging as promising therapeutic targets for various cancers.

Conclusions:

  • circRNAs possess unique properties making them valuable in cancer research.
  • Further investigation into circRNA functions and dysregulation is crucial for cancer therapy.
  • circRNAs hold significant promise as biomarkers and therapeutic targets, particularly in esophageal cancer.